CN
244-203-4
应用筛选条件
关键词:'244-203-4'
显示 1-23 共 23 条结果 关于 "244-203-4" 范围 技术文档
Quality Control Range Sheet- HCKP2-103 and HCKP2-203
Control 2 1287 - 2672 pg/mL Control 2 1926 - 4000 pg/ml
B7H6 Control 1 117 - 244 pg/mL MICA Control 1 233 - 484 pg/ml
Product Information - M8158
Pharmacopoeia, 31st ed.,
Reynolds, J. E. F., ed., Royal Pharmaceutical
Society (London, UK: 1996), pp. 244-245.
3. Rousseau, N., et al., Effect of beta-lactams on
peptidoglycan metabolism of Haemophilus
Data Sheet - F7176
Biophys. Res.
Commun., 244, 187 (1998).
2. Givol, D., and Yayon, A., FASEB. J., 6, 3362
(1992).
3. Baird, A., et al., Curr. Opin. Neurobiol., 4, 78
(1994).
4. Fernig, F.G., and Gallagher
HPLC Analysis of Synthetic (Spice) Cannabinoids on AscentisR Express F5
of each component in acetonitrile,
1 mL/ampoule
S-047 Spice Cannabinoid Mix 3 (RCS-4, RCS-8, JWH-015, JWH-
203, JWH-210, AM-2233), 100 µg/mL of each component
in acetonitrile, 1 mL/ampoule
S-027
Quality Control Range Sheet- B6062-101A and B6062-201A
mL
Control 2 652 – 1355 pg/mL Control 2 356 – 740 pg/mL
ENA-78 Control 1 117 – 244 pg/mL IL-23 Control 1
Product Information Sheet - P4394
Speelmans, G. et al., Biochem., 36, 10545, (1997).
13. Daugaard, G. et al., J. Pharmacol. Exp. Ther., 244,
1081, (1988).
14. Lippard, S.J., Science, 218, 1075, (1982).
15. The Merck Index, 12th ed.
XP725 Antibody Number-Lot Number 071M4826
3.1 193 194 195 196 217 218 219 220 241 242 243 244 265 266 267 268
3.2 197 198 199 200 221 222 223 224 245 246 247 248 269 270 271 272
3.3 201 202 203 204 225 226 227
Product Information Sheet - ROAMYC
mg (lyophilized)
200
m
m
Cat. No. 11 667 203 001
Cat. No. 11 667 203 001
5 mg (1 ml
Article: Evaluation of immunological parameters in pit bull terrier-type dogs with juvenile onset generalized demodicosis and age-matched healthy pit bull terrier-type dogs
error and statistical power in reports of
small animal clinical trials. J Am Vet Med Assoc 2014; 244:
1,075–1,080.
36. Taylor JR. Introduction to error analysis, the study of uncertain-
ties in
Advanced Applications of Engineered Nanomaterials
Grandjean, F.,
Rebbouh, L., Long, G.J., J. Appl. Phys., �00�, 95, 6804. (4) Ross, C.,
Annual Review of Materials Research, �001, 31, 203. (5) Cho, S.J.,
Jarrett, B.R., Louie, A.Y., Kauzlarich, S.M., Nanotechnology
XP725 Antibody List Lot 129K4831
I9783 3840 KPNA4 M NP_002259.1 y y y
722 Transportin 1 T0825 3842 TNPO1 M NP_002261.3 y y y
203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d
205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP
XP725 Antibody List Lot 129K4830
I9783 3840 KPNA4 M NP_002259.1 y y y
722 Transportin 1 T0825 3842 TNPO1 M NP_002261.3 y y y
203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d
205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP
XP725 Antibody List Lot 089K4791
I9783 3840 KPNA4 M NP_002259.1 y y y
722 Transportin 1 T0825 3842 TNPO1 M NP_002261.3 y y y
203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d
205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
µg 16-247
IC NEUT
Anti-phospho-EGFR (Tyr1173), Alexa Fluor 488 9H2 H M FC IF M IgG1κ 25 µg 16-244
Conjugate
Anti-phospho-EGFR (Tyr1173), Alexa Fluor 555 9H2 H M FC IF M IgG1κ 25 µg 16-245
List of Antibodies
C5351 P y n/d n/d
201 Cystatin A C3095 M y n/d n/d
202 Cytohesin-1 C8979 M y n/d n/d
203 Cytokeratin peptide 4 C5176 M y n/d n/d
204 Cytokeratin CK5 C7785 M y n/d n/d
205 Cytokeratin peptide
XP725 Worksheet for Lot Number 071M4826
CY3/5 C0992
241 2 2 1 1 Caspase 7 C1104
242 2 2 1 2 Caspase 7 C1104
243 2 2 1 3 Caspase 8 C3101
244 2 2 1 4 Caspase 8 C3101
245 2 2 1 5 Caspase 8 C2976
246 2 2 1
3D BIOPRINTING: Printing a Brighter Future
(202) Ning, L.; Betancourt, N.; Schreyer, D. J.; Chen, X. ACS Biomater. Sci.
Eng. 2018, 4, 3906–3918.
(203) Moon, J. J.; Saik, J. E.; Poché, R. A.; Leslie-Barbick, J. E.; Lee, S.-H.;
Smith, A. A.;
3D BIOPRINTING: Printing a Brighter Future
(202) Ning, L.; Betancourt, N.; Schreyer, D. J.; Chen, X. ACS Biomater. Sci.
Eng. 2018, 4, 3906–3918.
(203) Moon, J. J.; Saik, J. E.; Poché, R. A.; Leslie-Barbick, J. E.; Lee, S.-H.;
Smith, A. A.;
Halal Certificate
FG W358118 B64741 HC-23SIBB96
243. 3-OCTANOL NATURAL, 97%, FCC, FG W358126 A82290 HC-23SIUI03
244. 3-OCTANONE 98%, FG W280305 B10421 HC-23SIMV23
245. 3-OCTYL ACETATE 98%, FCC, FG W358304 B53781
Halal Certificate
FG W358118 B64741 HC-22SIWY18
243. 3-OCTANOL NATURAL, 97%, FCC, FG W358126 A82290 HC-22SI5Z24
244. 3-OCTANONE 98%, FG W280305 B10421 HC-22SI3544
245. 3-OCTYL ACETATE 98%, FCC, FG W358304 B53781
XP725 Antibody List
1475 CSTA NP_005204.1 M y n/d n/d
202 Cytohesin-1 C8979 9267 PSCD1 NP_059430.2 M y n/d n/d
203 Cytokeratin peptide 4 C5176 3851 KRT4 NP_002263.2 M y n/d n/d
204 Cytokeratin CK5 C7785 3875 KRT18 NP_954657.1
XP725 Antibody List 013M4793
1475 CSTA NP_005204.1 M y n/d n/d
202 Cytohesin-1 C8979 9267 PSCD1 NP_059430.2 M y n/d n/d
203 Cytokeratin peptide 4 C5176 3851 KRT4 NP_002263.2 M y n/d n/d
204 Cytokeratin CK5 C7785 3875 KRT18 NP_954657.1
Material Matters Volume 15 number 2 Batteries & Solar Cells
Sustain. Energy Rev. 2012, 16, 244–252.
(3) Correa-Baena, J.-P.; Saliba, M.; Buonassisi, T.; Grätzel, M.; Abate, A.;
Tress, W.; Hagfeldt, A. Science 2017, 358, 739–744.
(4) Saliba, M.; Correa-Baena, J